-
-
Call more information
660-596-2224 -
The FDA has approved a nasal spray version of naloxone hydrochloride (marketed as Narcan) to stop or reverse opioid overdose. The drug was previously approved only as an injection; the new version, says the agency, is both easier for first responders to administer and eliminates the risk for needlestick contamination. The drug is indicated for […]
Read MoreAuthors: McCarthy ML et al., Ann Emerg Med 2015 Oct 13; A large trial shows that ultrasound helps with moderate or difficult anticipated IV access when lines are placed by emergency department technicians. Multiple small studies since 2005 have shown that ultrasound guidance improves success of peripheral intravenous (IV) line placement when access is difficult. These researchers […]
Read MorePatients who had emergency general surgery are at high risk for readmission within 30 days of their hospitalizations due to surgical-site infections and gastrointestinal complications, according to new research published in the Journal of the American Medical Association Surgery. Joaquim M. Havens, M.D., of Brigham and Women’s Hospital, Boston and colleagues examined factors for 30-day readmissions of […]
Read MoreAlthough opioids are frequently prescribed to treat chronic lower back pain, new research suggests these powerful medications may be less effective in some patients. A study published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists® (ASA®), found patients who were prescribed opioids to treat chronic lower back […]
Read MoreAuthors: Kelly A. Pollak, MD et al Anesthesiology 11 2015, Vol.123, 1133-1141. Background: The authors examined changes in the frequency of pain medicine malpractice claims and associated treatment modalities and outcomes over time. Methods: The authors analyzed trends in pain medicine claims from 1980 to 2012 in the Anesthesia Closed Claims Project database by binary logistic regression on year […]
Read More